SCHEMBL6768898

SCHEMBL6768898

O=C(c1ccccn1)c1oc2ccc(Cc3ccc(F)cc3)cc2c1O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B14 Q9BPX1 1/20 0.39
KMT2A Q03164 3/20 0.38
MEN1 O00255 1/20 0.38
NQO1 P15559 1/20 0.38
MAPT P10636 3/20 0.36
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
HSP90AA1 P07900 1/20 0.36
OPRK1 P41145 1/20 0.36
HTT P42858 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
CNR2 P34972 2/20 0.36
CNR1 P21554 1/20 0.36
HSD17B10 Q99714 2/20 0.36
PTGS1 P23219 1/20 0.36
PTGS2 P35354 1/20 0.36
GRM2 Q14416 1/20 0.35
NMT2 O60551 1/20 0.35
NMT1 P30419 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3222162 0.88 NQO1 (0.40) KMT2ANQO1MAPTLMNAHTT
SCHEMBL13427718 0.78 MAPT (0.43) KMT2AMEN1NQO1MAPTKDM4E
SCHEMBL3220870 0.77 NQO1 (0.44) KMT2AMEN1NQO1MAPTKDM4E
SCHEMBL3220428 0.73 NQO1 (0.40) KMT2ANQO1MAPTLMNAHTT
SCHEMBL6720338 0.72 NQO1 (0.53) NQO1LMNAHTTCNR2GPR55
SCHEMBL1941913 0.71 ALDH1A1 (0.47) KMT2AMEN1MAPTKDM4ELMNA
SCHEMBL3220608 0.67 CES1 (0.43) HSD17B14KMT2AMEN1MAPTKDM4E
SCHEMBL13255593 0.67 PARP1 (0.40) KMT2AMEN1KDM4ELMNAHSP90AA1
SCHEMBL6720324 0.66 NQO1 (0.52) KMT2AMEN1NQO1KDM4ELMNA
SCHEMBL29560650 0.65 KMT2A (0.72) HSD17B14KMT2AMEN1MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040039060-A1 Inhibitor for enzyme having two divalent metal ions as active centers SHIONOGI & CO., LTD. (JP) 2004-02-26 US disclosed
EP-1297834-A1 INHIBITOR FOR ENZYME HAVING TWO DIVALENT METAL IONS AS ACTIVE CENTERS SHIONOGI & CO., LTD. (JP) 2003-04-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040039060-A1 Inhibitor for enzyme having two divalent metal ions as active centers GAA, CMA1, MMEL1 HSD17B14 166/4885KMT2A 1875/4885MEN1 2593/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.